Identifying protein partners of CLN8, An ER-resident protein involved in neuronal ceroid lipofuscinosis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 3, 2013, Pages 529-540

  Passantino, Rosa ^a   Cascio, Caterina ^a   Deidda, Irene ^a   Galizzi, Giacoma ^a   Russo, Domenica ^a   Spedale, Gianpiero ^a,b   Guarneri, Patrizia ^a  

^a CNR   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CLN8; EPMR; Protein interaction; Split ubiquitin yeast two hybrid; VLINCL

Indexed keywords

ANTIBODY; BRAIN PROTEIN; PROTEIN BNIP3; PROTEIN BNIP3L; PROTEIN C14ORF1; PROTEIN CLN8; PROTEIN GATE16; PROTEIN HERG28; PROTEIN STX8; PROTEIN VAPA; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DNA LIBRARY; ENDOPLASMIC RETICULUM; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIPID TRANSPORT; MOUSE; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBODY FORMATION; BLOTTING, WESTERN; BRAIN; COS CELLS; ENDOPLASMIC RETICULUM; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; NEOPLASM PROTEINS; NEURONAL CEROID-LIPOFUSCINOSES; PROTO-ONCOGENE PROTEINS; RABBITS; TUMOR SUPPRESSOR PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES; VESICULAR TRANSPORT PROTEINS;

MAMMALIA;

EID: 84871911332     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.10.030     Document Type: Article

References (67)

1. Kousi M., Lehesjoki A.E., Mole S.E. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum. Mutat. 2012, 33:42-63.
2. Jalanko A., Braulke T. Neuronal ceroid lipofuscinoses. Biochim. Biophys. Acta 2009, 1793:697-709.
3. Nosková L., Stránecký V., Hartmannová H., Přistoupilová A., Barešová V., Ivánek R., Hůlková H., Jahnová H., Van Der Zee J., Staropoli J.F., Sims K.B., Tyynelä J., Van Broeckhoven C., Nijssen P.C., Mole S.E., Elleder M., Kmoch S. Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis. Am. J. Hum. Genet. 2011, 89:241-252.
4. Benitez B.A., Alvarado D., Cai Y., Mayo K., Chakraverty S., Norton J., Morris J.C., Sands M.S., Goate A., Cruchaga C. Exome-sequencing confirms DNAJC5 mutations as cause of adult neuronal ceroid-lipofuscinosis. PLoS One 2011, 6:e26741.
5. Smith K.R., Damiano J., Franceschetti S., Carpenter S., Canafoglia L., Morbin M., Rossi G., Pareyson D., Mole S.E., Staropoli J.F., Sims K.B., Lewis J., Lin W.L., Dickson D.W., Dahl H.H., Bahlo M., Berkovic S.F. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am. J. Hum. Genet. 2012, 90:1102-1107.
6. Bras J., Verloes A., Schneider S.A., Mole S.E., Guerreiro R.J. Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum. Mol. Genet. 2012, 21:2646-2650.
7. Staropoli J.F., Karaa A., Lim E.T., Kirby A., Elbalalesy N., Romansky S.G., Leydiker K.B., Coppel S.H., Barone R., Xin W., MacDonald M.E., Abdenur J.E., Daly M.J., Sims K.B., Cotman S.L. A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system. Am. J. Hum. Genet. 2012, 91:202-208.
8. Getty A.L., Pearce D.A. Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function. Cell. Mol. Life Sci. 2011, 68:453-474.
9. Luiro K., Yliannala K., Ahtiainen L., Maunu H., Järvelä I., Kyttälä A., Jalanko A. Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Hum. Mol. Genet. 2004, 13:3017-3027.
10. Getty A.L., Benedict J.W., Pearce D.A. A novel interaction of CLN3 with nonmuscle myosin-IIB and defects in cell motility of Cln3(-/-) cells. Exp. Cell Res. 2011, 317:51-69.
11. Benedict J.W., Getty A.L., Wishart T.M., Gillingwater T.H., Pearce D.A. Protein product of CLN6 gene responsible for variant late-onset infantile neuronal ceroid lipofuscinosis interacts with CRMP-2. J. Neurosci. Res. 2009, 87:2157-2166.
12. Uusi-Rauva K., Kyttälä A., Van Der Kant R., Vesa J., Tanhuanpää K., Neefjes J., Olkkonen V.M., Jalanko A. Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments. Cell. Mol. Life Sci. 2012, 69:2075-2089.
13. Wang P., Ju W., Wu D., Wang L., Yan M., Zou J., He B., Jenkins E.C., Brown W.T., Zhong N. A two-dimensional protein fragmentation-proteomic study of neuronal ceroid lipofuscinoses: identification and characterization of differentially expressed proteins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011, 879:304-316.
14. Fossale E., Wolf P., Espinola J.A., Lubicz-Nawrocka T., Teed A.M., Gao H., Rigamonti D., Cattaneo E., MacDonald M.E., Cotman S.L. Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis. BMC Neurosci. 2004, 5:57.
15. Cao Y., Espinola J.A., Fossale E., Massey A.C., Cuervo A.M., MacDonald M.E., Cotman S.L. Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J. Biol. Chem. 2006, 281:20483-20493.
16. Cao Y., Staropoli J.F., Biswas S., Espinola J.A., MacDonald M.E., Lee J.M., Cotman S.L. Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells. PLoS One 2011, 6:e17118.
17. Ranta S., Zhang Y., Ross B., Lonka L., Takkunen E., Messer A., Sharp J., Wheeler R., Kusumi K., Mole S., Liu W., Soares M.B., Bonaldo M.F., Hirvasniemi A., De La Chapelle A., Gilliam T.C., Lehesjoki A.E. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat. Genet. 1999, 23:233-236.
18. Ranta S., Topcu M., Tan S., Tegelberg H., Ustübütün A., Saatci I., Dufke A., Enders H., Pohl K., Alembik Y., Mitchell W.A., Mole S.E., Lehesjoki A.E. Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum. Mutat. 2004, 23:300-305.
19. Cannelli N., Cassandrini D., Bertini E., Striano P., Fusco L., Gaggero R., Specchio N., Biancheri R., Vigevano F., Bruno C., Simonati A., Zara F., Santorelli F.M. Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: another genetic hit in the Mediterranean. Neurogenetics 2006, 7:111-117.
20. Vantaggiato C., Redaelli F., Falcone S., Perrotta C., Tonelli A., Bondioni S., Morbin M., Riva D., Saletti V., Bonaglia M.C., Giorda R., Bresolin N., Clementi E., Bassi M.T. A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological function. Hum. Mutat. 2009, 30:1104-1116.
21. Messer A., Plummer J., MacMillen M.C., Frankel W.N. Genetics of primary and timing effects in the mnd mouse. Am. J. Med. Genet. 1995, 57:361-364.
22. Lonka L., Kyttälä A., Ranta S., Jalanko A., Lehesjoki A.E. The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum. Hum. Mol. Genet. 2000, 9:1691-1697.
23. Vance J.E., Stone S.J., Faust J.R. Abnormalities in mitochondria-associated membrane and phospholipid biosynthetic enzymes in the mnd/mnd mouse model of neuronal ceroid lipofuscinosis. Biochim. Biophys. Acta 1997, 1344:286-299.
24. Rusyn E., Mousallem T., Persaud-Sawin D., Miller S., Boustany R.M. CLN3p Impacts Galactosylceramide Transport, Raft Morphology, and Lipid Content. Pediatr. Res. 2008, 63:625-631.
25. Kuronen M., Hermansson M., Manninen O., Zech I., Talvitie M., Laitinen T., Gröhn O., Somerharju P., Eckhardt M., Cooper J.D., Lehesjoki A.E., Lahtinen U., Kopra O. Galactolipid deficiency in the early pathogenesis of neuronal ceroid lipofuscinosis model Cln8(mnd): implications to delayed myelination and oligodendrocyte maturation. Neuropathol. Appl. Neurobiol. 2012, 38:471-486.
26. Bertamini M., Marzani B., Guarneri R., Guarneri P., Bigini P., Mennini T., Curti D. Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system. Eur. J. Neurosci. 2002, 16:2291-2296.
27. Guarneri R., Russo D., Cascio C., D'Agostino S., Galizzi G., Bigini P., Mennini T., Guarneri P. Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis. Brain Res. 2004, 1014:209-220.
28. Kolikova J., Afzalov R., Surin A., Lehesjoki A.E., Khiroug L. Deficient mitochondrial Ca(2+) buffering in the Cln8(mnd) mouse model of neuronal ceroid lipofuscinosis. Cell Calcium 2011, 50:491-501.
29. Galizzi G., Russo D., Deidda I., Cascio C., Passantino R., Guarneri R., Bigini P., Mennini T., Drago G., Guarneri P. Different early ER-stress responses in the CLN8(mnd) mouse model of neuronal ceroid lipofuscinosis. Neurosci. Lett. 2011, 488:258-262.
30. Hermansson M., Käkelä R., Berghäll M., Lehesjoki A.E., Somerharju P., Lahtinen U. Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case study. J. Neurochem. 2005, 95:609-617.
31. Wei H., Kim S.J., Zhang Z., Tsai P.C., Wisniewski K.E., Mukherjee A.B. ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Hum. Mol. Genet. 2008, 17:469-477.
32. Winter E., Ponting C.P. TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains?. Trends Biochem. Sci. 2002, 27:381-383.
33. Lonka L., Salonen T., Siintola E., Kopra O., Lehesjoki A.E., Jalanko A. Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells. J. Neurosci. Res. 2004, 76:862-871.
34. Persaud-Sawin D.A., Mousallem T., Wang C., Zucker A., Kominami E., Boustany R.M. Neuronal ceroid lipofuscinosis: a common pathway?. Pediatr. Res. 2007, 61:146-152.
35. Guillas I., Jiang J.C., Vionnet C., Roubaty C., Uldry D., Chuard R., Wang J., Jazwinski S.M., Conzelmann A. Human homologues of LAG1 reconstitute Acyl-CoA-dependent ceramide synthesis in yeast. J. Biol. Chem. 2003, 278:37083-37091.
36. Lyly A., Von Schantz C., Heine C., Schmiedt M.L., Sipilä T., Jalanko A., Kyttälä A. Novel interactions of CLN5 support molecular networking between neuronal ceroid lipofuscinosis proteins. BMC Cell Biol. 2009, 10:83.
37. Heine C., Quitsch A., Storch S., Martin Y., Lonka L., Lehesjoki A.E., Mole S.E., Braulke T. Topology and endoplasmic reticulum retention signals of the lysosomal storage disease-related membrane protein CLN6. Mol. Membr. Biol. 2007, 24:74-87.
38. Stagljar I., Korostensky C., Johnsson N., Te Heesen S. A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:5187-5192.
39. Lev S., Ben Halevy D., Peretti D., Dahan N. The VAP protein family: from cellular functions to motor neuron disease. Trends Cell Biol. 2008, 18:282-290.
40. Sagiv Y., Legesse-Miller A., Porat A., Elazar Z. GATE-16, a membrane transport modulator, interacts with NSF and the Golgi v-SNARE GOS-28. EMBO J. 2000, 19:1494-1504.
41. Kabeya Y., Mizushima N., Yamamoto A., Oshitani-Okamoto S., Ohsumi Y., Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J. Cell Sci. 2004, 117:2805-2812.
42. Weidberg H., Shvets E., Shpilka T., Shimron F., Shinder V., Elazar Z. LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J. 2010, 29:1792-1802.
43. Lonka L., Aalto A., Kopra O., Kuronen M., Kokaia Z., Saarma M., Lehesjoki A.E. The neuronal ceroid lipofuscinosis Cln8 gene expression is developmentally regulated in mouse brain and up-regulated in the hippocampal kindling model of epilepsy. BMC Neurosci. 2005, 6:27.
44. Teuling E., Ahmed S., Haasdijk E., Demmers J., Steinmetz M.O., Akhmanova A., Jaarsma D., Hoogenraad C.C. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J. Neurosci. 2007, 27:9801-9815.
45. Ottolenghi C., Daizadeh I., Ju A., Kossida S., Renault G., Jacquet M., Fellous A., Gilbert W., Veitia R. The genomic structure of c14orf1 is conserved across eukarya. Mamm. Genome 2000, 11:786-788.
46. Mo C., Bard M. Erg28p is a key protein in the yeast sterol biosynthetic enzyme complex. J. Lipid Res. 2005, 46:1991-1998.
47. Kaiser S.E., Brickner J.H., Reilein A.R., Fenn T.D., Walter P., Brunger A.T. Structural basis of FFAT motif-mediated ER targeting. Structure 2005, 13:1035-1045.
48. Kawano M., Kumagai K., Nishijima M., Hanada K. Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT. J. Biol. Chem. 2006, 281:30279-30288.
49. Peretti D., Dahan N., Shimoni E., Hirschberg K., Lev S. Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. Mol. Biol. Cell 2008, 19:3871-3884.
50. Skehel P.A., Fabian-Fine R., Kandel E.R. Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1101-1106.
51. Weir M.L., Xie H., Klip A., Trimble W.S. VAP-A binds promiscuously to both v- and tSNAREs. Biochem. Biophys. Res. Commun. 2001, 286:616-621.
52. Amarilio R., Ramachandran S., Sabanay H., Lev S. Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J. Biol. Chem. 2005, 280:5934-5944.
53. Rocha N., Kuijl C., Van Der Kant R., Janssen L., Houben D., Janssen H., Zwart W., Neefjes J. Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 glued and late endosome positioning. J. Cell Biol. 2009, 185:1209-1225.
54. Bonifacino J.S., Glick B.S. The mechanisms of vesicle budding and fusion. Cell 2004, 116:153-166.
55. Prekeris R., Yang B., Oorschot V., Klumperman J., Scheller R.H. Differential roles of syntaxin 7 and syntaxin 8 in endosomal trafficking. Mol. Biol. Cell 1999, 10:3891-3908.
56. Kittler J.T., Rostaing P., Schiavo G., Fritschy J.M., Olsen R., Triller A., Moss S.J. The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABAA receptors. Mol. Cell. Neurosci. 2001, 18:13-25.
57. Cooper J.D., Russell C., Mitchison H.M. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Biochim. Biophys. Acta 2006, 1762:873-889.
58. Luiro K., Kopra O., Lehtovirta M., Jalanko A. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Hum. Mol. Genet. 2001, 10:2123-2131.
59. Ahtiainen L., Van Diggelen O.P., Jalanko A., Kopra O. Palmitoyl protein thioesterase 1 is targeted to the axons in neurons. J. Comp. Neurol. 2003, 455:368-377.
60. Kirkin V., McEwan D.G., Novak I., Dikic I. A role for ubiquitin in selective autophagy. Mol. Cell 2009, 34:259-269.
61. Novak I., Kirkin V., McEwan D.G., Zhang J., Wild P., Rozenknop A., Rogov V., Löhr F., Popovic D., Occhipinti A., Reichert A.S., Terzic J., Dötsch V., Ney P.A., Dikic I. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep. 2010, 11:45-51.
62. Zhang J., Ney P.A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 2009, 16:939-946.
63. Settembre C., Fraldi A., Jahreiss L., Spampanato C., Venturi C., Medina D., De Pablo R., Tacchetti C., Rubinsztein D.C., Ballabio A. A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet. 2008, 17:119-129.
64. Koike M., Shibata M., Waguri S., Yoshimura K., Tanida I., Kominami E., Gotow T., Peters C., Von Figura K., Mizushima N., Saftig P., Uchiyama Y. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am. J. Pathol. 2005, 167:1713-1728.
65. Cannelli N., Garavaglia B., Simonati A., Aiello C., Barzaghi C., Pezzini F., Cilio M.R., Biancheri R., Morbin M., Dalla Bernardina B., Granata T., Tessa A., Invernizzi F., Pessagno A., Boldrini R., Zibordi F., Grazian L., Claps D., Carrozzo R., Mole S.E., Nardocci N., Santorelli F.M. Variant late infantile ceroid lipofuscinoses associated with novel mutations in CLN6. Biochem. Biophys. Res. Commun. 2009, 379:892-897.
66. Thelen M., Damme M., Schweizer M., Hagel C., Wong A.M., Cooper J.D., Braulke T., Galliciotti G. Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis. PLoS One 2012, 7:e35493.
67. Zhang C.K., Stein P.B., Liu J., Wang Z., Yang R., Cho J.H., Gregersen P.K., Aerts J.M., Zhao H., Pastores G.M., Mistry P.K. Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation. Am. J. Hematol. 2012, 87:377-383.